Reversible cardiogenic shock following 5-Fluorouracil infusion

Author： Ferté Charles   Gomez Roca Carlos   Loriot Yohann   Bahleda Rastislav   Moldovan Cristian   Cohen Ariel   Izzedine Hassan   Soria Jean-Charles   Ederhy Stephane  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.28, Iss.4, 2010-08, pp. : 531-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorouracil: Cardiogenic shock: case report

By  

Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Fosphenytoin: Cardiogenic shock: case report

By  

Reactions Weekly, Vol. 1, Iss. 1379, 2011-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Morphine: Cardiogenic shock: case report

By  

Reactions Weekly, Vol. 1, Iss. 1362, 2011-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer

By Burmeister Bryan   Walpole Euan   D’Arcy Nancy   Burmeister Elizabeth   Cox Sharon   Thomson Damien   Harvey Jennifer   Smithers B.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 275-279

Springer Publishing Company

Access to resources Recommend Favorite